2019 annual financial data
Spero Therapeutics 2019 Net margin
Spero Therapeutics 2019 net margin with verified reported values.
Direct answer
Net margin was -1,268.98%.
Operating income was -63,216,000 USD and net income was -60,175,000 USD.
Operating cash flow was -50,020,000 USD.
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,742,000 USD
- Operating income
- -63,216,000 USD
- Net income
- -60,175,000 USD
- Operating cash flow
- -50,020,000 USD